Promising ALS Drug Disappoints: Setback for Patients

Bookmark Article



Bookmark Article


On “Psychology Behind the Headlines,” hosts Jessica Reyes, Patricia Wu, and guest therapist Ryan Heapy discuss the withdrawal of a much-anticipated ALS medication after it was shown to be no more effective than a placebo.

ALS Patients Let Down

Patients who hoped this drug would be a lifesaver or at least slow the progression of this devastating disease are facing disappointment and potential despair.

A Questionable Process

The fact that this drug was approved with minimal evidence and came with a high price tag raises questions about the drug development and approval system.

The Emotional Toll

ALS is a challenging diagnosis on its own; experiencing the roller coaster of hope and subsequent disappointment creates an added psychological burden for patients and caregiver

Editorial Team
Editorial Team
At the heart of MHTN - America's pioneering 24/7 Mental Health TV Network - is our editorial team, a dynamic group of professionals united by a shared commitment to transforming the conversation around mental health. Our team is composed of seasoned journalists, mental health experts, researchers, and storytellers, each bringing a wealth of experience and a passion for advocacy.


Please enter your comment!
Please enter your name here

Read more


Related Articles